Title : DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A.

Pub. Date : 2010 Oct 27

PMID : 21060866






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A. alisporivir peptidylprolyl isomerase G Homo sapiens
2 DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A. alisporivir peptidylprolyl isomerase G Homo sapiens
3 DEB025/Debio 025 (Alisporivir) is a cyclophilin (Cyp)-binding molecule with potent anti-hepatitis C virus (HCV) activity both in vitro and in vivo. alisporivir peptidylprolyl isomerase G Homo sapiens
4 DEB025/Debio 025 (Alisporivir) is a cyclophilin (Cyp)-binding molecule with potent anti-hepatitis C virus (HCV) activity both in vitro and in vivo. alisporivir peptidylprolyl isomerase G Homo sapiens